Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial - Diver, S; Khalfaoui, L; Emson, C; CASCADE study investigators (Lancet Respir Med, 2021)